Although whether these influences of OSA are sufficient, independently of obesity, to contribute significantly to the “hypertension” remains unsettled, irisin would still be an attractive tool for treating or intervening hypertension and OSA considering its relationship with human adipocytes, myocytes, and cardiovascular system. The gene discussed is FNDC5; the disease is hypertensive disorder.